Innovative Therapeutic Protein Production in Chicken Eggs ID: 2024-055
An advanced system leveraging chicken eggs for cost-effective and scalable production of therapeutic proteins.
Photo by starlineart - stock.adobe.com
Technology Overview
This technology introduces a groundbreaking method for producing therapeutic proteins by genetically modifying chicken primordial germ cells (cPGCs) to express therapeutic proteins in egg whites. Utilizing Recombinase-Mediated Cassette Exchange (RMCE), this approach enables precise insertion of therapeutic gene cassettes into the chicken genome, allowing for the large-scale production of biologics in a cost-efficient manner.
Key Advantages
- Significantly reduces production costs compared to traditional mammalian cell cultures
- Enhances production efficiency and scalability through the use of chicken eggs
- Facilitates easy purification of proteins due to their expression in egg whites
- Supports ethical and sustainable production practices
Problems Addressed
- High cost and limited scalability of traditional biologics production methods
- Complexity and inefficiency in producing therapeutic proteins
- Environmental and ethical concerns associated with mammalian cell cultures
Additional Information
Technology ID: 2024-055
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 28 March, 2025
Connect with the Tech Transfer to:
- Meet with the technology manager
- Receive additional information
- Request a marketing plan report